Press release
Cancer Biomarkers Market to grow with 16.9% CAGR during 2021 to 2031
The global cancer biomarkers market size was USD 13.4 billion in 2021 and it is anticipated to reach USD 63.6 billion by 2031, growing at a CAGR of 16.9% from 2022-2031.Global Cancer Biomarkers report from Global Insight Services is the single authoritative source of intelligence on Cancer Biomarkers market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Read more about Cancer Biomarkers market here: https://www.globalinsightservices.com/reports/cancer-biomarkers-market/
Cancer biomarkers are substances or processes that indicate the presence of cancers in the human body, estimated by collecting samples such as stool, tumor tissue, blood, urine, or other tissues or bodily fluids. Biomarkers may be formed by the cancer tissue itself or by other cells in the body in response to cancer. They enhance cancer detection and assist in high-speed noninvasive diagnosis using genomics and proteomics.
To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS10251
Major Players in Global Cancer Biomarkers Market
The major key players in the cancer biomarkers market are F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), bioMérieux SA (US), Becton, Dickinson and Company (US), Merck Millipore (US)
Global Cancer Biomarkers Market Segmentation
The report analyses the global cancer biomarkers market based on biomarker type, cancer type, profiling technologies, application, and region.
Global Cancer Biomarkers Market by Biomarker Type
Based on biomarker type, it is segmented into protein biomarkers, genetic biomarkers, and others. The protein biomarker segment is likely to dominate the market during the forecast period. The key factors such as increasing research on cancer biomarkers are propelling the growth of the market.
Global Cancer Biomarkers Market by Cancer Type
Based on cancer type, it is segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, and others. The breast cancer segment is anticipated to dominate the market during the forecast period. The key factors such as the increasing incidence of cancer across the globe are boosting the growth of the market.
For In-Depth Competitive Analysis, Purchase this Report - https://www.globalinsightservices.com/inquiry-before-buying/GIS10251
With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market to grow with 16.9% CAGR during 2021 to 2031 here
News-ID: 2749984 • Views: …
More Releases from Global Insight Services
Rice Bran Oil Market Is Anticipated To Expand From $7.6 Billion In 2024 To $13.1 …
Market Overview
The Rice Bran Oil Market has emerged as a dynamic segment within the global edible oil industry, owing to its exceptional nutritional benefits and wide applications. Extracted from the outer layer of rice grains, rice bran oil is recognized for its high smoke point, light taste, and health-enhancing properties. Increasing consumer awareness of healthy cooking oils, combined with the growing prevalence of lifestyle-related health concerns such as obesity and…
Continuous Renal Replacement Therapy Market Is Anticipated To Expand From $1.95 …
Market Overview
The Continuous Renal Replacement Therapy (CRRT) Market plays a vital role in modern critical care medicine, particularly for patients suffering from acute kidney injury (AKI). Unlike traditional dialysis methods, CRRT provides continuous and gentle filtration of blood, making it well-suited for unstable patients in intensive care units. The market encompasses dialysis machines, hemofilters, replacement fluids, and related consumables that support hospitals and ICUs in managing critically ill individuals. Growth…
Advanced Air Mobility Market Poised to Grow from $8.7 Billion in 2024 to $45.2 B …
The Advanced Air Mobility (AAM) market is entering an era of rapid transformation, poised to expand from $8.7 billion in 2024 to $45.2 billion by 2034, growing at a CAGR of approximately 17.9%. This remarkable growth reflects the increasing demand for next-generation aerial transportation systems, primarily built around electric vertical takeoff and landing (eVTOL) aircraft and drones. These innovations aim to revolutionize short-distance travel, enhance urban connectivity, and alleviate congestion…
Life Science Tools Market Poised to Grow from $95.7 Billion in 2024 to $170.2 Bi …
The Life Science Tools Market is experiencing remarkable growth, expanding from an estimated $95.7 billion in 2024 to $170.2 billion by 2034, at a CAGR of around 5.9%. This market serves as the backbone of research and development in biotechnology, pharmaceuticals, and healthcare, offering an extensive range of products like advanced instruments, reagents, consumables, and software solutions. These tools enable researchers to conduct experiments, develop diagnostics, and advance therapeutic innovations,…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
